Systems Oncology Approach to Optimize Ovarian Cancer Treatment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorUniversity of Helsinki

About this trial

The overall aim is to identify effective therapeutic strategies to ovarian cancer (OC) using serial tumor, ascites and blood samples, and carry out state-of-the-art sequencing approaches, functional assays and associated bioinformatics to understand mechanisms behind chemoresistance in OC and identify new treatment options for OC patients. In this observational trial, we will systematically collect, analyze and interpret functional, molecular and clinical data from real-world ovarian cancer patients.

Eligibility criteria

Qualifiers

Patients diagnosed with ovarian cancer

Available tumor tissue/blood samples

Disqualifiers

Inability to consent to the study

Trial design

Treatments tested in this trial

  • Biomolecular profiling

Treatment groups

No treatment groups listed

Sponsors and collaborators

University of Helsinki

Lead sponsor

Helsinki University Central Hospital

Collaborator